A 24-year-old woman is evaluated in the outpatient psychiatric clinic following a recent hospitalization for an acute manic episode. The physician and patient agree to initiate pharmacotherapy with lithium carbonate for mood stabilization.
Arrange the following steps regarding the baseline evaluation, therapeutic drug monitoring, and long-term surveillance of this patient in the correct chronological sequence.
- 1Obtain baseline serum creatinine, thyroid-stimulating hormone (TSH), calcium, and a urine pregnancy test.
- 2Initiate lithium therapy and allow approximately 5 to 7 days for the drug to reach steady-state kinetics.
- 3Draw a trough serum lithium concentration 12 hours after the most recent evening dose.
- 4Adjust the daily dosage based on the trough level to achieve an acute therapeutic target of 0.8 to 1.2 mEq/L.
- 5Transition to maintenance monitoring by checking serum lithium levels, renal function, and thyroid function every 6 to 12 months.
Answer
The correct sequence begins with checking baseline labs, then initiating the drug and waiting for steady-state (5-7 days), followed by drawing a 12-hour trough level, adjusting the dose accordingly, and finally transitioning to long-term 6-12 month maintenance monitoring.
The standard protocol for initiating lithium involves ensuring baseline safety (creatinine, TSH, calcium, pregnancy), achieving steady-state kinetics (5-7 days), verifying the steady-state trough (12 hours post-dose), titrating to the therapeutic window (0.8-1.2 mEq/L), and finally committing to long-term monitoring (6-12 months) for chronic adverse effects.
Step-by-Step Solution
Key Concept
The safe initiation and monitoring of lithium requires assessing baseline renal/thyroid function, allowing 5-7 days to reach steady-state before drawing a 12-hour trough level, adjusting the dose to a narrow therapeutic index, and establishing lifelong bi-annual or annual organ surveillance.